News

The saga of Once Upon a Time in Shaolin, the one-of-a-kind Wu-Tang Clan album that Martin “pharma bro” Shkreli bought for ...
The price tag behind the government's sale of Wu-Tang Clan's Once Upon a Time in Shaolin album has been revealed. According ...
Fact checked by Stella Osoba In 2015, Martin Shkreli captured national headlines when he raised the price of a life-saving medication by 5,000%—from $13.50 to $750 per pill. But the audacious price ...
Convicted “Pharma Bro” Martin Shkreli has finally been ousted as boss of the pharmaceutical company he founded, The Post has learned. Activist shareholders booted the group of directors still ...
Martin Shkreli has been sued in New York by a digital art collective that said it paid $4.75 million for a one-of-a-kind album by the hip-hop group Wu-Tang Clan, only to learn that the convicted ...
Martin Shkreli, famous for jacking up the price of a generic drug, is touting a weird deal he says he made with Barron Trump. But his reputation for fraud precedes him.
A federal judge on Friday banned the controversial former pharmaceutical executive Martin Shkreli from ever working in that industry again and ordered him to return $64.6 million in wrongfully ...
Imprisoned felon Martin Shkreli – nicknamed "Pharma Bro" – was busted for using a contraband phone to discuss pharmaceutical industry business matters with associates from behind bars.
Martin Shkreli, controversial drug CEO, arrested for fraud 02:32. For many social media users, Martin Shkreli's arrest Thursday on charges of securities fraud is cause for holiday cheer.
Martin Shkreli, convicted of fraud for actions around his hedge fund, is going to prison. So far, Elizabeth Holmes, who sold falsehoods about her blood-testing business, is not. By James B. Stewart ...
Martin Shkreli, the “Pharma Bro” who gained notoriety for unapologetically raising drug prices, has been released from federal prison in Pennsylvania and transferred to a halfway house.
Shkreli's father was also present for the reading of the verdict. Former drug company executive Martin Shkreli exits the U.S. District Court in Brooklyn, New York, July 28, 2017.